Public preferences for vaccination programmes during pandemics caused by pathogens transmitted through respiratory droplets – a discrete choice experiment in four European countries, 2013
Open Access
- 2 June 2016
- journal article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 21 (22) , 30247
Abstract
This study aims to quantify and compare preferences of citizens from different European countries for vaccination programme characteristics during pandemics, caused by pathogens which are transmitted through respiratory droplets. Internet panel members, nationally representative based on age, sex, educational level and region, of four European Union Member States (Netherlands, Poland, Spain, and Sweden, n = 2,068) completed an online discrete choice experiment. These countries, from different geographical areas of Europe, were chosen because of the availability of high-quality Internet panels and because of the cooperation between members of the project entitled Effective Communication in Outbreak Management: development of an evidence-based tool for Europe (ECOM). Data were analysed using panel latent class regression models. In the case of a severe pandemic scenario, vaccine effectiveness was the most important characteristic determining vaccination preference in all countries, followed by the body that advises on vaccination. In Sweden, the advice of family and/or friends and the advice of physicians strongly affected vaccine preferences, in contrast to Poland and Spain, where the advice of (international) health authorities was more decisive. Irrespective of pandemic scenario or vaccination programme characteristics, the predicted vaccination uptakes were lowest in Sweden, and highest in Poland. To increase vaccination uptake during future pandemics, the responsible authorities should align with other important stakeholders in the country and communicate in a coordinated manner.Keywords
This publication has 41 references indexed in Scilit:
- The Effect of Perceived Risks on the Demand for Vaccination: Results from a Discrete Choice ExperimentPLOS ONE, 2013
- Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysisBMJ, 2012
- Monitoring the level of government trust, risk perception and intention of the general public to adopt protective measures during the influenza A (H1N1) pandemic in the NetherlandsBMC Public Health, 2011
- Reasons for low influenza vaccination coverage – a cross-sectional survey in PolandCroatian Medical Journal, 2011
- Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control StudyPLOS Medicine, 2011
- Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccineBMC Infectious Diseases, 2010
- Conducting Discrete Choice Experiments to Inform Healthcare Decision MakingPharmacoEconomics, 2008
- Strategies for mitigating an influenza pandemicNature, 2006
- Mitigation strategies for pandemic influenza in the United StatesProceedings of the National Academy of Sciences, 2006
- Simultaneous conjoint measurement: A new type of fundamental measurementJournal of Mathematical Psychology, 1964